About this trial
This is the prospective, observational cohort study (Radiogenomics-Urinary), which aims to explore the relationship between the imaging information of urologic cancer patients, tumor microenvironment and the prognosis of urologic cancer patients.
Eligibility criteria
Qualifiers
Patients treated for urologic cancer in Wuhan Union Hospital from August 2024 to August 2027;
Aged > 18 years old;
At least one CT scan or MRI scan before treatment;
Tissue biopsy pathological examination confirmed the diagnosis of the above tumors.
Disqualifiers
Poor image quality;
Incomplete clinical data or loss of follow-up;
Presence of another primary malignancy other than urologic cancer;
Unclear pathological diagnosis。
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Locations
1Sponsors and collaborators
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead sponsor